E
ABVC BioPharma, Inc. ABVC
$1.32 $0.2624.53%
Recommendation
Sell
Prev Close
$0.86
Volume
2,018,597
Avg Vol (90D)
442,198
Market Cap
$10.53M
Dividend & Yield
--
52-Week Range
$0.40 - $1.73
P/E (TTM)
--
EPS (TTM)
-$0.9844
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
ABVC BioPharma (NASDAQ:ABVC) Trading Up 0.4% - What's Next?
3/9/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Decrease in Short Interest
2/14/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest
1/29/2025 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 148.2% in December
12/27/2024 - Ticker Report
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, ...
12/19/2024 - GuruFocus
ABVC BioPharma believes ABV-1504 can fill void in market after Prozac
12/19/2024 - TipRanks Financial Blog
ABVC BioPharma believes ABV-1504 can fill void in market after Prozac
12/19/2024 - The Fly
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
12/19/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest
12/14/2024 - Ticker Report
ABVC BioPharma gets $200K in cash from OncoX BioPharma
12/11/2024 - Seeking Alpha - Healthcare
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, ...
12/11/2024 - GuruFocus
ABVC BioPharma receives $200,000 cash payment from OncoX
12/11/2024 - The Fly
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
12/11/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Increase in Short Interest
11/30/2024 - Ticker Report
ABVC BioPharma reports Q3 EPS (2c) vs (82c) last year
11/14/2024 - The Fly
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
11/14/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Growth in Short Interest
11/14/2024 - Ticker Report
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb
10/22/2024 - Seeking Alpha - Healthcare
ABVC BioPharma receives $50,000 in incremental licensing fees
10/22/2024 - The Fly
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
10/22/2024 - Globe Newswire
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update
10/14/2024 - Ticker Report
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Decreases By 19.1%
9/28/2024 - Ticker Report
Mateon Therapeutics (OTCMKTS:MATN) & ABVC BioPharma (NASDAQ:ABVC) Critical Analysis
9/18/2024 - Ticker Report
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Expands By 8.1%
9/17/2024 - Ticker Report
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 29.4% in August
8/29/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$509.80K
EBITDA (TTM)
-$6.29M
EBIT (TTM)
-$6.32M
Net Income (TTM)
-$8.24M
Balance Sheet
Total Assets (Q)
$14.46M
Total Debt (Q)
$2.75M
Total Liabilities (Q)
$6.48M
Book Value Per Share (Q)
$0.6977
Cash Flow
Cash from Operations (TTM)
-$1.80M
Cash from Investing (TTM)
$154.20K
Cash from Financing (TTM)
$1.49M
Net Change in Cash (TTM)
-$351.10K
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 10 and 14 (est)
Price History
Loading...
Beta
0.52
7-Day Total Return
98.50%
30-Day Total Return
189.16%
60-Day Total Return
123.73%
90-Day Total Return
164.00%
Year to Date Total Return
105.83%
1-Year Total Return
-3.65%
2-Year Total Return
-79.79%
3-Year Total Return
-94.75%
5-Year Total Return
-94.50%
52-week Low
Feb 10, 2025 - $0.40
52-week High
Apr 25, 2024 - $1.73
Valuation
Market Cap
$10.53M - Nano Cap
Enterprise Value
$12.69M
Price/Sales (TTM)
20.98
Price/Book (Q)
1.23
Dividends and Shares
Shares Outstanding
12.41M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.abvcpharma.com
Phone Number
510 668 0881
Address
44370 Old Warm Springs Boulevard
Fremont, CA 94538
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which... more
NASDAQ 04/01/2025 4:00PM Eastern Quotes delayed
Weiss Ratings